Frontlight ResearchEarly access
CompletedNo phase
Adipose-derived Stem Cells Combined With Excimer Light in the Treatment of Stable Vitiligo
Key facts
- Who runs it
- Tanta University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 15 people enrolled
- Started
- 1 Aug 2023
- Ended
- 1 Sept 2025
- Type of study
- Interventional
- Treatments tested
- Adipose-derived Stem Cells Combined With Excimer Light
- Record updated
- 8 July 2026
Who can take part
- Age
- 15 years to 52 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Patients with two or more similar patches of stable vitiligo "absence of new patches of depigmentation or enlargement of the pre-existing patches" for 6 months at least
- Patients who will accept to be enrolled in the study and will sign an informed consent
Who cannot take part
- Patients who received topical treatment for vitiligo during the last month, or systemic treatment during the past three months before the study
- Current bacterial or viral infection in the treatment area
- Patients with uncontrolled systemic disease such as diabetes or hypertension
- Patients with hepatitis B or C virus infection
- Patients with any other skin disease
- Patients with bleeding or coagulopathy disorders
- Unstable vitiligo for more than 6 months
- Patients with unrealistic expectation
- Very thin patients "poor donor areas"
- Pregnancy and lactation
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aimed to assess the efficacy and safety of intradermal injection of adipose-derived stem cells, alone and combined with excimer light in treatment of stable vitiligo.
The group in the trial
- Study groupTreatment being tested
Patients with two or more similar patches of stable vitiligo "absence of new patches of depigmentation or enlargement of the pre-existing patches" for 6 months at least
Treatment: Adipose-derived Stem Cells Combined With Excimer Light
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 8 July 2026